U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083232) titled 'The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats' on July 16.
Brief Summary: The aim of the present study is to evaluate the prophylactic effect of Sitagliptin, Pioglitazone and Dapagliflozine on Isoprenaline induced myocardial infarction in type II diabetic rats.
Study Start Date: Oct. 30, 2024
Study Type: INTERVENTIONAL
Condition:
Diabetic
Myocardial Infarction
Intervention:
DIETARY_SUPPLEMENT: standard normal diet
Group I: formed of normal animals. They were allowed standard normal diet and water. They received no drugs
DRUG: low dose Streptozotocin
Non-treated diabetic...